Opportunity
SAM #75F40126SS131706
FDA Seeks Biopharmaceutics Classification System / Automated Solubility Apparatus
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
July 06, 2026
Respond By
July 16, 2026
Identifier
75F40126SS131706
NAICS
334516
The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), is seeking sources for a Biopharmaceutics Classification System (BCS) / Automated Solubility Apparatus. - Government Buyer: - Agency: U.S. Food and Drug Administration - Sub-agency: Center for Drug Evaluation and Research (CDER) - Office: Office of Pharmaceutical Quality (OPQ) - Products Requested: - Biopharmaceutics Classification System (BCS) / Automated Solubility Apparatus - Quantity: 1 - Must be newly manufactured, latest model, and made in America - Technical requirements: - Maintains sample temperature at 37°C - Adjustable stirring speed - Operates multiple sample containers simultaneously - Withdraws samples at different time points - Filters or centrifuges samples before sampling - Optional features: dilution, pH monitoring, direct HPLC connection - Includes delivery, installation, on-site training for 6 scientists, and minimum one-year warranty (parts and labor) - Services Requested: - Delivery, installation, on-site performance testing, and training for at least 6 scientists - Support for network computer - Unique Requirements: - Apparatus must be made in America - On-site training and warranty included - OEMs and Vendors: - No specific OEMs or vendors are named; opportunity is open to manufacturers meeting requirements
Description
See Attached Sources Sought 75F40126SS131706